REGENXBIO Inc. (RGNX) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$2,632
Total Return
-73.68%
CAGR
-23.44%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.78% |
| Median | -2.51% |
| Best | +101.06% |
| Worst | -50.31% |
| % of Windows Positive | 43.2% |
1-Year (252 Trading Days)
| Average | -21.37% |
| Median | -29.45% |
| Best | +116.83% |
| Worst | -74.96% |
| % of Windows Positive | 16.9% |
3-Year (756 Trading Days)
| Average | -62.77% |
| Median | -64.88% |
| Best | -33.08% |
| Worst | -84.84% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -88.38% |
| Average Drawdown | -56.31% |
| Drawdown Duration | 1148 Trading Days (Unrecovered) |
| Sortino Ratio | -0.07 |
| Calmar Ratio | -0.27 |
| CVaR (5%) | -9.30% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -35.42% (-78.47% ann.) | $3541.66 | $0.00 | $0.00 | $0.00 |
| 2025 | +86.29% | +$8628.69 | $0.00 | $0.00 | $0.00 |
| 2024 | -56.94% | $5693.59 | $0.00 | $0.00 | $0.00 |
| 2023 | -20.86% | $2085.54 | $0.00 | $0.00 | $0.00 |
| 2022 | -30.64% | $3064.22 | $0.00 | $0.00 | $0.00 |
| 2021 | -27.91% | $2791.00 | $0.00 | $0.00 | $0.00 |
| 2020 | +10.72% | +$1071.52 | $0.00 | $0.00 | $0.00 |
| 2019 | -2.34% | $233.61 | $0.00 | $0.00 | $0.00 |
| 2018 | +26.17% | +$2616.54 | $0.00 | $0.00 | $0.00 |
| 2017 | +79.25% | +$7924.54 | $0.00 | $0.00 | $0.00 |
| 2016 | +11.75% | +$1174.69 | $0.00 | $0.00 | $0.00 |
| 2015 partial | -45.48% (-87.88% ann.) | $4548.44 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | September 17, 2015 – February 19, 2020 | +77.37% | +13.83% | +$7737.27 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -48.10% | -99.94% | $4810.13 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -4.79% | -7.60% | $479.07 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -8.52% | -8.10% | $851.52 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -36.09% | -37.84% | $3609.37 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -41.40% | -25.05% | $4140.28 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -25.78% | -17.31% | $2577.80 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.